Dehydrated human amniotic membrane regulates tenocyte expression and angiogenesis in vitro: Implications for a therapeutic treatment of tendinopathy

• Published in: Journal of biomedical materials research. Part B, Applied biomaterials Applied biomaterials, 2022-04, Vol.110 (4), p.731-742
• Main Authors: Moreno, Sarah E., Massee, Michelle, Koob, Thomas J.
• Format: Article
• Language: English
• Subjects: Amnion; Amnion - metabolism; Amniotic membrane; Angiogenesis; Antagonists; Biomechanics; Biomedical materials; Cell culture; Chorion; Collagen; Complications; Dehydration; Extracellular matrix; Gene expression; Humans; Inflammation; Injuries; Interleukin 1; Materials research; Materials science; Matrix metalloproteinases; Mechanical properties; Membranes; Musculoskeletal system; Phenotypes; tendinopathy; Tendinopathy - metabolism; Tendinopathy - therapy; Tendon Injuries - metabolism; Tendons; Tenocytes
• ISSN: 1552-4973; 1552-4981
• DOI: 10.1002/jbm.b.34951

Tendon injuries are among the most common ailments of the musculoskeletal system. Prolonged inflammation and persistent vasculature are common complications associated with poor healing. Damaged tendon, replaced with scar tissue, never completely regains the native structural or biomechanical properties. This study evaluated the effects of micronized dehydrated human amnion/chorion membrane (μdHACM) on the inflammatory environment and hypervascularity associated with tendinopathy. Stimulation of human tenocytes with interleukin‐1 beta (IL1β) induced the expression of inflammatory and catabolic markers, resulting in secretion of active MMPs and type 3 collagen that is associated with a degenerative phenotype. Treatment with μdHACM diminished the effects of IL1β, reducing the expression of inflammatory genes, proteases, and extracellular matrix components, and decreasing the presence of active MMP and type 3 collagen. Additionally, a co‐culture model was developed to evaluate the effects of μdHACM on angiogenesis associated with tendinopathy. Micronized dHACM differentially regulated angiogenesis depending upon the cellular environment in which it was placed. This phenomenon can be explained in part through the detection of both angiogenic protagonists and antagonists in μdHACM. Observations from this study identify a mechanism by which μdHACM regulates inflammatory processes and angiogenesis in vitro, two key pathways implicated in tendinopathic injuries.